Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Pfizer Withdraws Oxbryta, But Overall Market Impact May Be Limited
EU Regulators Recommend Suspending Approval
Sep 26 2024
•
By
Alaric DeArment
• Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Blood and Clotting
More from Therapy Areas